XOMA
Insider trading & Transactions

Last updated: 18 Jun 2013

Transaction	Date	Insider	Security	Shares	Price per share	Total value
Option	18 Jun 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	3,130	N/A	N/A
Option	17 Jun 2013	VARIAN JOHN director director	Incentive Share Option (right to buy)	10,000	N/A	N/A
Sale	17 Jun 2013	VARIAN JOHN director director	Common Shares	10,000	N/A	N/A
Option	17 Jun 2013	VARIAN JOHN director director	Common Shares	10,000	N/A	N/A
Sale	11 Jun 2013	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Common Shares	10,000	N/A	N/A
Option	11 Jun 2013	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Incentive Share Option (right to buy)	10,000	N/A	N/A
Option	11 Jun 2013	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Common Shares	10,000	N/A	N/A
Sale	29 May 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	1,797	N/A	N/A
Option	28 May 2013	BOWES WILLIAM K JR director director	Restricted Stock Units	2,800	N/A	N/A
Option	28 May 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	4,667	N/A	N/A
Option	28 May 2013	WYSZOMIERSKI JACK L director director	Common Shares	2,800	N/A	N/A
Option	28 May 2013	BOWES WILLIAM K JR director director	Common Shares	2,800	N/A	N/A
Option	28 May 2013	WYSZOMIERSKI JACK L director director	Non-Qualified Share Option (right to buy)	2,800	N/A	N/A
Option	28 May 2013	VAN NESS W DENMAN director director	Restricted Stock Units	3,150	N/A	N/A
Option	28 May 2013	VAN NESS W DENMAN director director	Common Shares	3,150	N/A	N/A
Option	28 May 2013	WALBERT TIMOTHY P director director	Common Shares	2,800	N/A	N/A
Option	28 May 2013	WALBERT TIMOTHY P director director	Restricted Stock Units	2,800	N/A	N/A
Option	28 May 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Restricted Stock Units	4,667	N/A	N/A
Option	20 May 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Non-Qualified Share Option (right to buy)	785	N/A	N/A
Option	20 May 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	785	N/A	N/A
Sale	20 May 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	6,000	N/A	N/A
Option	15 May 2013	VARIAN JOHN director director	Common Shares	10,000	N/A	N/A
Sale	15 May 2013	VARIAN JOHN director director	Common Shares	10,000	N/A	N/A
Option	15 May 2013	VARIAN JOHN director director	Incentive Share Option (right to buy)	10,000	N/A	N/A
Option	14 May 2013	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Incentive Share Option (right to buy)	10,000	N/A	N/A
Sale	14 May 2013	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Common Shares	10,000	N/A	N/A
Option	14 May 2013	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Common Shares	10,000	N/A	N/A
Sale	18 Apr 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	6,000	N/A	N/A
Option	28 Mar 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	1,498	N/A	N/A
Sale	19 Mar 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	6,990	N/A	N/A
Option	18 Mar 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	18,205	N/A	N/A
Option	18 Mar 2013	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Restricted Stock Units	18,205	N/A	N/A
Option	31 Dec 2012	RUBIN PAUL D officer: Sr. VP Clinical Dev. & CMO officer: Sr. VP Clinical Dev. &..	Common Shares	833	N/A	N/A
Sale	14 Nov 2012	VARIAN JOHN director director	Common Shares	40,587	N/A	N/A
Sale	14 Nov 2012	KURLAND FRED officer: CFO & VP Finance officer: CFO & VP Finance	Common Shares	9,111	N/A	N/A
Sale	14 Nov 2012	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Common Shares	8,773	N/A	N/A
Option	13 Nov 2012	WYSZOMIERSKI JACK L director director	Common Shares	4,499	N/A	N/A
Option	13 Nov 2012	VARIAN JOHN director director	Common Shares	100,666	N/A	N/A
Option	13 Nov 2012	WALBERT TIMOTHY P director director	Common Shares	4,499	N/A	N/A
Option	13 Nov 2012	BOWES WILLIAM K JR director director	Common Shares	4,499	N/A	N/A
Option	13 Nov 2012	WYSZOMIERSKI JACK L director director	Restricted Stock Units	4,499	N/A	N/A
Option	13 Nov 2012	VAN NESS W DENMAN director director	Restricted Stock Units	6,876	N/A	N/A
Option	13 Nov 2012	VAN NESS W DENMAN director director	Common Shares	6,876	N/A	N/A
Option	13 Nov 2012	BOWES WILLIAM K JR director director	Restricted Stock Units	4,499	N/A	N/A
Option	13 Nov 2012	VARIAN JOHN director director	Restricted Stock Units	100,666	N/A	N/A
Option	13 Nov 2012	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Common Shares	22,653	N/A	N/A
Option	13 Nov 2012	WALBERT TIMOTHY P director director	Restricted Stock Units	4,499	N/A	N/A
Option	13 Nov 2012	SCANNON PATRICK J MD PHD officer: Exec. VP & CSO, other: E.. officer: Exec. VP & CSO, other:..	Restricted Stock Units	22,653	N/A	N/A
Option	13 Nov 2012	KURLAND FRED officer: CFO & VP Finance officer: CFO & VP Finance	Common Shares	22,596	N/A	N/A
Option	13 Nov 2012	KURLAND FRED officer: CFO & VP Finance officer: CFO & VP Finance	Restricted Stock Units	22,596	N/A	N/A

Showing 500 to 550 of 588 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

XOMA Insider trading & Transactions

Insider trading

Who is insider?

Similar companies insider trading:

XOMA
Insider trading & Transactions